451 related articles for article (PubMed ID: 25974737)
1. Stress-induced Aldosterone Hyper-Secretion in a Substantial Subset of Patients With Essential Hypertension.
Markou A; Sertedaki A; Kaltsas G; Androulakis II; Marakaki C; Pappa T; Gouli A; Papanastasiou L; Fountoulakis S; Zacharoulis A; Karavidas A; Ragkou D; Charmandari E; Chrousos GP; Piaditis GP
J Clin Endocrinol Metab; 2015 Aug; 100(8):2857-64. PubMed ID: 25974737
[TBL] [Abstract][Full Text] [Related]
2. Functional characterization of two novel germline mutations of the KCNJ5 gene in hypertensive patients without primary aldosteronism but with ACTH-dependent aldosterone hypersecretion.
Sertedaki A; Markou A; Vlachakis D; Kossida S; Campanac E; Hoffman DA; Sierra ML; Xekouki P; Stratakis CA; Kaltsas G; Piaditis GP; Chrousos GP; Charmandari E
Clin Endocrinol (Oxf); 2016 Dec; 85(6):845-851. PubMed ID: 27293068
[TBL] [Abstract][Full Text] [Related]
3. Histopathological and genetic characterization of aldosterone-producing adenomas with concurrent subclinical cortisol hypersecretion: a case series.
Fallo F; Castellano I; Gomez-Sanchez CE; Rhayem Y; Pilon C; Vicennati V; Santini D; Maffeis V; Fassina A; Mulatero P; Beuschlein F; Reincke M
Endocrine; 2017 Dec; 58(3):503-512. PubMed ID: 28405879
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical, genetic and clinical characterization of sporadic aldosterone-producing adenomas.
Monticone S; Castellano I; Versace K; Lucatello B; Veglio F; Gomez-Sanchez CE; Williams TA; Mulatero P
Mol Cell Endocrinol; 2015 Aug; 411():146-54. PubMed ID: 25958045
[TBL] [Abstract][Full Text] [Related]
5. Different cell compositions and a novel somatic
Zhao L; Wan J; Wang Y; Yang W; Liang Q; Wang J; Jin P
Front Endocrinol (Lausanne); 2023; 14():1068335. PubMed ID: 36960396
[TBL] [Abstract][Full Text] [Related]
6. Voltage-gated calcium channels in the human adrenal and primary aldosteronism.
Felizola SJ; Maekawa T; Nakamura Y; Satoh F; Ono Y; Kikuchi K; Aritomi S; Ikeda K; Yoshimura M; Tojo K; Sasano H
J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt B():410-6. PubMed ID: 25151951
[TBL] [Abstract][Full Text] [Related]
7. Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology.
Fardella CE; Mosso L; Gómez-Sánchez C; Cortés P; Soto J; Gómez L; Pinto M; Huete A; Oestreicher E; Foradori A; Montero J
J Clin Endocrinol Metab; 2000 May; 85(5):1863-7. PubMed ID: 10843166
[TBL] [Abstract][Full Text] [Related]
8. [Diagnosis and treatment outcome in primary aldosteronism based on a retrospective analysis of 187 cases].
Szücs N; Gláz E; Varga I; Tóth M; Kiss R; Patócs A; Jakab C; Perner F; Járay J; Horányi J; Dabasi G; Molnár F; Major L; Füto L; Rácz K; Tulassay Z
Orv Hetil; 2006 Jan; 147(2):51-9. PubMed ID: 16509213
[TBL] [Abstract][Full Text] [Related]
9. Primary aldosteronism in hypertensive patients: clinical implications and target therapy.
Papanastasiou L; Markou A; Pappa T; Gouli A; Tsounas P; Fountoulakis S; Kounadi T; Tsiama V; Dasou A; Gryparis A; Samara C; Zografos G; Kaltsas G; Chrousos G; Piaditis G
Eur J Clin Invest; 2014 Aug; 44(8):697-706. PubMed ID: 24909545
[TBL] [Abstract][Full Text] [Related]
10. Aldosterone suppression with dopamine infusion in low-renin hypertension.
Holland OB; Thomas C; Brown H; Schindewolf D; Hillier Y; Gomez-Sanchez C
J Clin Invest; 1983 Sep; 72(3):754-66. PubMed ID: 6309909
[TBL] [Abstract][Full Text] [Related]
11. The molecular basis of primary aldosteronism: from chimeric gene to channelopathy.
Lenzini L; Rossi GP
Curr Opin Pharmacol; 2015 Apr; 21():35-42. PubMed ID: 25555247
[TBL] [Abstract][Full Text] [Related]
12. The role of ACTH in the episodic release of aldosterone in patients with idiopathic adrenal hyperplasia, hypertension, and hyperaldosteronism.
Kem DC; Weinberger MH; Gomez-Sanchez C; Higgins JR; Kramer NJ
J Lab Clin Med; 1976 Aug; 88(2):261-70. PubMed ID: 182890
[TBL] [Abstract][Full Text] [Related]
13. Case Report: Primary Aldosteronism Due to Bilateral Aldosterone-Producing Micronodules With HISTALDO Classical and Contralateral Non-Classical Pathology.
Chen YJ; Peng KY; Chueh JS; Liao HW; Hsieh TY; Wu VC; Wang SM
Front Endocrinol (Lausanne); 2022; 13():816754. PubMed ID: 35399924
[TBL] [Abstract][Full Text] [Related]
14. A novel KCNJ5-insT149 somatic mutation close to, but outside, the selectivity filter causes resistant hypertension by loss of selectivity for potassium.
Kuppusamy M; Caroccia B; Stindl J; Bandulik S; Lenzini L; Gioco F; Fishman V; Zanotti G; Gomez-Sanchez C; Bader M; Warth R; Rossi GP
J Clin Endocrinol Metab; 2014 Sep; 99(9):E1765-73. PubMed ID: 25057880
[TBL] [Abstract][Full Text] [Related]
15. Colocalization of Wnt/β-Catenin and ACTH Signaling Pathways and Paracrine Regulation in Aldosterone-producing Adenoma.
De Sousa K; Abdellatif AB; Giscos-Douriez I; Meatchi T; Amar L; Fernandes-Rosa FL; Boulkroun S; Zennaro MC
J Clin Endocrinol Metab; 2022 Jan; 107(2):419-434. PubMed ID: 34570225
[TBL] [Abstract][Full Text] [Related]
16. A Chinese pedigree with glucocorticoid remediable aldosteronism.
Liu X; Jin L; Zhang H; Ma W; Song L; Zhou X; Cai J
Hypertens Res; 2021 Nov; 44(11):1428-1433. PubMed ID: 34462604
[TBL] [Abstract][Full Text] [Related]
17. A new presentation of the chimeric CYP11B1/CYP11B2 gene with low prevalence of primary aldosteronism and atypical gene segregation pattern.
Carvajal CA; Campino C; Martinez-Aguayo A; Tichauer JE; Bancalari R; Valdivia C; Trejo P; Aglony M; Baudrand R; Lagos CF; Mellado C; Garcia H; Fardella CE
Hypertension; 2012 Jan; 59(1):85-91. PubMed ID: 22083159
[TBL] [Abstract][Full Text] [Related]
18. In familial hyperaldosteronism type I, hybrid gene-induced aldosterone production dominates that induced by wild-type genes.
Stowasser M; Gartside MG; Taylor WL; Tunny TJ; Gordon RD
J Clin Endocrinol Metab; 1997 Nov; 82(11):3670-6. PubMed ID: 9360524
[TBL] [Abstract][Full Text] [Related]
19. Positive association between KCNJ5 rs2604204 (A/C) polymorphism and plasma aldosterone levels, but also plasma renin and angiotensin I and II levels, in newly diagnosed hypertensive Chinese: a case-control study.
Wang H; Weng C; Chen H
J Hum Hypertens; 2017 Jul; 31(7):457-461. PubMed ID: 28102195
[TBL] [Abstract][Full Text] [Related]
20. Macrolides for KCNJ5-mutated aldosterone-producing adenoma (MAPA): design of a study for personalized diagnosis of primary aldosteronism.
Maiolino G; Ceolotto G; Battistel M; Barbiero G; Cesari M; Amar L; Caroccia B; Padrini R; Azizi M; Rossi GP
Blood Press; 2018 Aug; 27(4):200-205. PubMed ID: 29409357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
